CTXR vs GWW · rev $7.1M vs P/E 27, rev $9.76B
Citius Pharmaceuticals Inc (CTXR) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
CTXR currently screens at market cap $13.4M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the CTXR and GWW stock pages for the full models.
Not investment advice.